首页> 美国卫生研究院文献>Immunology >A novel mechanism of nuclear factor-κB regulation by adenoviral protein 14.7K
【2h】

A novel mechanism of nuclear factor-κB regulation by adenoviral protein 14.7K

机译:腺病毒蛋白14.7K调控核因子κB的新机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Viruses have evolved many different ways to evade immune attacks. The adenoviral E3 protein 14·7K effectively inhibits antiviral immunity and inflammation. However, the underlying mechanism for this effect is unclear. Here we show that 14·7K is a potent inhibitor of nuclear factor (NF)-κB transcriptional activity following Toll-like receptor (TLR) or tumour necrosis factor (TNF) receptor signalling. The inhibition of the NF-κB activity occurs downstream of IκBα degradation and NF-κB translocation into the nucleus. Analysis of NF-κB DNA binding reveals that 14·7K specifically inhibits p50 homodimer DNA binding and that this inhibition is mediated through the interaction of 14·7K with p50. We propose that 14·7K inhibits NF-κB activity through directly blocking p50 binding to DNA and that this is the basis for its anti-inflammatory properties. Our data also indicate a role for p50 homodimer-dependent transcription in inflammation.
机译:病毒已经进化出许多逃避免疫攻击的方式。腺病毒E3蛋白14·7K有效抑制抗病毒免疫力和炎症。但是,这种作用的潜在机制尚不清楚。在这里,我们显示14·7K是Toll样受体(TLR)或肿瘤坏死因子(TNF)受体信号转导后的核因子(NF)-κB转录活性的有效抑制剂。 NF-κB活性的抑制发生在IκBα降解和NF-κB易位进入核的下游。 NF-κBDNA结合的分析表明14·7K特异性抑制p50同二聚体DNA结合,并且这种抑制作用是通过14·7K与p50的相互作用介导的。我们认为14·7K通过直接阻断p50与DNA的结合来抑制NF-κB的活性,这是其抗炎特性的基础。我们的数据还表明p50同源二聚体依赖性转录在炎症中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号